1月6日，截至港股收盘，恒生指数下跌0.36%，报19688.29点。昭衍新药（06127.HK）收报8.93港元/股，上涨2.64%，成交量148.89万股，成交额1330.1万港元，振幅2.64%。最近一个月来，昭衍新药累计跌幅4.92%，今年来累计跌幅6.95%，跑输恒生指数-1.49%的跌幅。财务数据显示，截至2024年9月30日，昭衍新药实现营业总收入13.35亿元，同比减少15.87%...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.